Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia

Allogeneic stem cell transplantation remains the standard treatment for resistant advanced chronic myeloid leukemia and Philadelphia chromosome–positive acute lymphoblastic leukemia. Relapse is the major cause of treatment failure in both diseases. Post-allo-SCT administration of TKIs could potentia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Varda-Bloom, Nira, Danylesko, Ivetta, Shouval, Roni, Eldror, Shiran, Lev, Atar, Davidson, Jacqueline, Rosenthal, Esther, Volchek, Yulia, Shem-Tov, Noga, Yerushalmi, Ronit, Shimoni, Avichai, Somech, Raz, Nagler, Arnon
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352130/
https://ncbi.nlm.nih.gov/pubmed/27880933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13439
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados